{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:14:36Z","timestamp":1778541276865,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["521-2014-6711"],"award-info":[{"award-number":["521-2014-6711"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017\\u201303953"],"award-info":[{"award-number":["2017\\u201303953"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["03953"],"award-info":[{"award-number":["03953"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113699","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T11:37:10Z","timestamp":1626176230000},"page":"113699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-5808","authenticated-orcid":false,"given":"Andrea","family":"Benediktsdottir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Zamaratski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-6981","authenticated-orcid":false,"given":"Anders","family":"Karl\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-6367","authenticated-orcid":false,"given":"Sherry L.","family":"Mowbray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-9182","authenticated-orcid":false,"given":"Diarmaid","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113699_bib1","series-title":"Drug Design: Methodology, Concepts, and Mode-Of-Action","author":"Klebe","year":"2013"},{"key":"10.1016\/j.ejmech.2021.113699_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cmdc.201200585","article-title":"Carboxylic acid (Bio)lsosteres in drug design","volume":"8","author":"Carlo","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113699_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/13543776.2012.698264","article-title":"Sulfonamides: a patent review","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113699_bib4","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/anie.201610456","article-title":"Sulfonimidamides in medicinal and agricultural chemistry","volume":"56","author":"Chinthakindi","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113699_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2016.09.091","article-title":"Sulfoximines from a medicinal chemist's perspective: physicochemical and in\u00a0vitro parameters relevant for drug discovery","volume":"126","author":"Frings","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/jm960673l","article-title":"Sulfonimidamide analogs of oncolytic sulfonylureas","volume":"40","author":"Toth","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cmdc.201200014","article-title":"Sulfonimidamides as sulfonamides bioisosteres: rational evaluation through synthetic, in\u00a0vitro, and in\u00a0vivo studies with \u03b3-secretase inhibitors","volume":"7","author":"Sehgelmeble","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113699_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsmedchemlett.9b00285","article-title":"N-Trifluoromethylthiolated Sulfonimidamides and Sulfoximines: Anti-microbial, anti-mycobacterial, and cytotoxic activity","volume":"10","author":"Thota","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113699_bib9","first-page":"281","article-title":"Synthesis of a sulfonimidamide-based analog of Tasisulam and its biological evaluation in the melanoma cell lines SKMel23 and A375, skin pharmacol","volume":"29","author":"Steinkamp","year":"2017","journal-title":"Physiol."},{"key":"10.1016\/j.ejmech.2021.113699_bib10","first-page":"309","article-title":"Pathogens and Global Health Antimicrobial resistance: a global multifaceted phenomenon Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Glob. Health"},{"key":"10.1016\/j.ejmech.2021.113699_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113699_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113699_bib13","author":"Paetzel"},{"key":"10.1016\/j.ejmech.2021.113699_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj2820539","article-title":"On the catalytic mechanism of prokaryotic leader peptidase 1","volume":"282","author":"Black","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113699_bib15","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/jb.175.16.4957-4961.1993","article-title":"Evidence that the catalytic activity of prokaryote leader peptidase depends upon the operation of a serine-lysine catalytic dyad","volume":"175","author":"Black","year":"1993","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2021.113699_bib16","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1074\/jbc.M110983200","article-title":"Crystal structure of a bacterial signal peptidase apoenzyme. Implications for signal peptide binding and the Ser-Lys dyad mechanism","volume":"277","author":"Paetzel","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib17","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1021\/jm1016126","article-title":"Initial efforts toward the optimization of arylomycins for antibiotic activity","volume":"54","author":"Roberts","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-018-0483-6","article-title":"Optimized arylomycins are a new class of Gram-negative antibiotics","volume":"561","author":"Smith","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113699_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7164\/antibiotics.55.571","article-title":"Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. T\u00fc 6075. II. Structure elucidation","volume":"55","author":"H\u00f6ltzel","year":"2002","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2021.113699_bib20","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1128\/AAC.00726-12","article-title":"Broadening the spectrum of \u03b2-lactam antibiotics through inhibition of signal peptidase type I, antimicrob","volume":"56","author":"Therien","year":"2012","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2021.113699_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0960-894X(95)00052-U","article-title":"Penem inhibitors of bacterial signal peptidase","volume":"5","author":"Allsop","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113699_bib22","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1055\/s-2003-40882","article-title":"Synthesis of (5S)-Tricyclic penems as novel and potent inhibitors of bacterial signal peptidases","volume":"11","author":"Hu","year":"2003","journal-title":"Synthesis (Stuttg)"},{"key":"10.1016\/j.ejmech.2021.113699_bib23","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1128\/JB.00224-12","article-title":"Inhibition of the sole type I signal peptidase of Mycobacterium tuberculosis is bactericidal under replicating and nonreplicating conditions","volume":"194","author":"Ollinger","year":"2012","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2021.113699_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0223-5234(03)00040-0","article-title":"Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to \u03b1-ketoamide inhibitors","volume":"38","author":"Bruton","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib25","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bmcl.2009.03.064","article-title":"Substrate based peptide aldehyde inhibits bacterial type I signal peptidase","volume":"19","author":"Buzder-Lantos","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113699_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bmc.2016.12.003","article-title":"Design, synthesis and in\u00a0vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB)","volume":"25","author":"De Rosa","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib27","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ejmech.2018.08.086","article-title":"Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase","volume":"157","author":"Sza\u0142aj","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib28","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ejoc.201801541","article-title":"Synthesis of sulfonimidamide-based amino acid building blocks with orthogonal protecting groups","author":"Chinthakindi","year":"2019","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib29","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/ejoc.202000108","article-title":"Solid phase synthesis of sulfonimidamide pseudopeptides and library generation","author":"Chinthakindi","year":"2020","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113699_bib30","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1016\/j.tet.2005.08.031","article-title":"Amide bond formation and peptide coupling","volume":"61","author":"Montalbetti","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113699_bib31","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1128\/jb.178.19.5712-5718.1996","article-title":"Molecular cloning and expression of the spsB gene encoding an essential type I signal peptidase from Staphylococcus aureus","volume":"178","author":"Cregg","year":"1996","journal-title":"J.\u00a0Bacteriol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:41:18Z","timestamp":1778539278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"alternative-id":["S0223523421005481"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113699","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113699"}}